Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Adults: United States, 2021-2022
- PMID: 38085820
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Adults: United States, 2021-2022
Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem illness characterized by activity-limiting fatigue, worsening of symptoms after activity, and other symptoms (1). It affects all age, sex, and racial and ethnic groups and costs the U.S. economy about $18-$51 billion annually (2-5). This report describes the percentage of adults who had ME/CFS at the time of interview by selected demographic and geographic characteristics based on data from the 2021-2022 National Health Interview Survey (NHIS).
All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical